Biosynex SA (FR:ALBIO) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Biosynex SA, a leading health diagnostics group, has announced its 2025 financial calendar, starting with the release of its 2024 annual revenue on January 13. The company, known for its rapid tests and molecular biology solutions, continues to expand its presence in 95 countries with a strong focus on innovation in healthcare diagnostics.
For further insights into FR:ALBIO stock, check out TipRanks’ Stock Analysis page.
